Sabby Management, LLC Biocept Inc Transaction History

Sabby Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.24 - $0.62 $216 - $558	-900 Reduced 2.95%	29,602 $10,000
Q1 2022 May 16, 2022	BUY	$1.83 - $3.97 $21,663 - $46,996	11,838 Added 63.43%	30,502 $71,000
Q4 2021 Feb 14, 2022	BUY	$3.43 - $4.22 $64,017 - $78,762	18,664 New	18,664 $68,000
Q3 2021 Nov 15, 2021	SELL	$3.39 - $4.34 $260,663 - $333,711	-76,892 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.03 - $5.07 $62,174 - $78,219	15,428 Added 25.1%	76,892 $322,000
Q1 2021 May 17, 2021	BUY	$4.74 - $7.94 $141,659 - $237,294	29,886 Added 94.64%	61,464 $313,000
Q4 2020 Feb 16, 2021	BUY	$4.31 - $6.16 $136,101 - $194,520	31,578 New	31,578 $140,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.